We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
+$224M
Cap. Flow %
177.31%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Sector Composition

1 Healthcare 39.95%
2 Consumer Staples 5.72%
3 Consumer Discretionary 5.14%
4 Technology 3.35%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAB
476
DELISTED
Cabela's Inc
CAB
-6,500
Closed -$333K
CAB
477
PUT
DELISTED
Cabela's Inc
CAB
-15,000
Closed -$24K
MJN
478
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
-16,500
Closed -$105K
LLTC
479
CALL
DELISTED
Linear Technology Corp
LLTC
-5,600
Closed -$12K
LLTC
480
DELISTED
Linear Technology Corp
LLTC
-10,774
Closed -$604K
LLTC
481
PUT
DELISTED
Linear Technology Corp
LLTC
-11,900
Closed -$32K
EMC
482
DELISTED
EMC CORPORATION
EMC
-22,500
Closed -$611K
RLYP
483
CALL
DELISTED
RELYPSA INC COM
RLYP
-167,000
Closed -$334K
RLYP
484
PUT
DELISTED
RELYPSA INC COM
RLYP
-30,000
Closed -$24K
TYC
485
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
-141,149
Closed -$622K
TYC
486
PUT
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
-41,924
Closed -$105K
SHPG
487
CALL
DELISTED
Shire pic
SHPG
-20,000
Closed -$147K
SHPG
488
PUT
DELISTED
Shire pic
SHPG
-4,200
Closed -$3K
MDVN
489
CALL
DELISTED
MEDIVATION, INC.
MDVN
-42,100
Closed -$189K
MDVN
490
DELISTED
MEDIVATION, INC.
MDVN
-119,135
Closed -$7.18M
MDVN
491
PUT
DELISTED
MEDIVATION, INC.
MDVN
-1,500
Closed -$2K
QLIK
492
CALL
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
-25,500
Closed -$2K
ARMH
493
CALL
DELISTED
ARM HOLDINGS PLC ADS
ARMH
-10,000
Closed -$26K

Similar funds

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.